1. Home
  2. VCEL vs FCNCP Comparison

VCEL vs FCNCP Comparison

Compare VCEL & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • FCNCP
  • Stock Information
  • Founded
  • VCEL 1989
  • FCNCP N/A
  • Country
  • VCEL United States
  • FCNCP United States
  • Employees
  • VCEL N/A
  • FCNCP 16021
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCP Major Banks
  • Sector
  • VCEL Health Care
  • FCNCP Finance
  • Exchange
  • VCEL Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • VCEL 2.1B
  • FCNCP N/A
  • IPO Year
  • VCEL 1997
  • FCNCP N/A
  • Fundamental
  • Price
  • VCEL $40.62
  • FCNCP $21.38
  • Analyst Decision
  • VCEL Strong Buy
  • FCNCP
  • Analyst Count
  • VCEL 8
  • FCNCP 0
  • Target Price
  • VCEL $62.00
  • FCNCP N/A
  • AVG Volume (30 Days)
  • VCEL 427.8K
  • FCNCP N/A
  • Earning Date
  • VCEL 07-31-2025
  • FCNCP N/A
  • Dividend Yield
  • VCEL N/A
  • FCNCP N/A
  • EPS Growth
  • VCEL 521.85
  • FCNCP N/A
  • EPS
  • VCEL 0.05
  • FCNCP N/A
  • Revenue
  • VCEL $238,541,000.00
  • FCNCP N/A
  • Revenue This Year
  • VCEL $23.03
  • FCNCP N/A
  • Revenue Next Year
  • VCEL $24.52
  • FCNCP N/A
  • P/E Ratio
  • VCEL $777.12
  • FCNCP N/A
  • Revenue Growth
  • VCEL 14.80
  • FCNCP N/A
  • 52 Week Low
  • VCEL $37.39
  • FCNCP N/A
  • 52 Week High
  • VCEL $63.00
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 44.61
  • FCNCP 51.87
  • Support Level
  • VCEL $39.39
  • FCNCP $21.27
  • Resistance Level
  • VCEL $43.57
  • FCNCP $21.90
  • Average True Range (ATR)
  • VCEL 1.60
  • FCNCP 0.24
  • MACD
  • VCEL -0.24
  • FCNCP -0.03
  • Stochastic Oscillator
  • VCEL 29.43
  • FCNCP 28.77

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.

Share on Social Networks: